If we are successful in getting this pathway to biosimilars moving then my fear is with a product sitting on the market that could cost 30 percent less we are going to be behind this avalanche of pharmaceutical advertising that will keep the market away from the biosimilars.
Chris Murphy: “If we are successful in getting this pathway to biosimilars moving then my fear is with a product sitting on the market…”
Editor's note · Context
Senator Murphy expresses concern over pharmaceutical advertising hindering biosimilar adoption.
Share
More from Chris Murphy
With Democrats on the verge of regaining control in Washington, it’s imperative that we offer a new approach to our policy in the Gulf that reflects America’s interests.
I’ve been a vocal critic of Saudi Arabia and the Crown Prince. But, I think it’s important to be here to disagree and be honest and candid about those disagreements.
It’s important for the Crown Prince to hear not just from the Trump Administration, but from people who want a different path.
Three years ago, Hamas terrorists unleashed terror on Israeli civilians, killing over a thousand innocent people and taking hundreds of others hostage. No amount of time will fully heal the grief of this unconscionable attack. My heart…





